Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-015092
Filing Date
2024-05-07
Accepted
2024-05-07 16:18:09
Documents
68
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q plse20240331_10q.htm   iXBRL 10-Q 1198437
2 EXHIBIT 31.1 ex_642897.htm EX-31.1 14154
3 EXHIBIT 32.1 ex_642898.htm EX-32.1 5838
  Complete submission text file 0001437749-24-015092.txt   5832643

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA plse-20240331.xsd EX-101.SCH 54119
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plse-20240331_cal.xml EX-101.CAL 36906
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plse-20240331_def.xml EX-101.DEF 401744
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE plse-20240331_lab.xml EX-101.LAB 300787
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plse-20240331_pre.xml EX-101.PRE 433640
72 EXTRACTED XBRL INSTANCE DOCUMENT plse20240331_10q_htm.xml XML 772012
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

EIN.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37744 | Film No.: 24922192
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)